Market Closed

RNTX
Rein Therapeutics
$ 0.5521
-1.41%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Rein Therapeutics News

Latest Rein Therapeutics Stock News & RNTX Headlines

Rein Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
13 days ago | globenewswire.com
Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress
2 months ago | globenewswire.com
Rein Therapeutics to Present at Upcoming September Investor Conferences
2 months ago | globenewswire.com
Here's Why You Should Add RNTX Stock to Your Portfolio Now
2 months ago | zacks.com
Brokerages Set Rein Therapeutics Inc. (NASDAQ:RNTX) PT at $6.00
3 months ago | defenseworld.net
Rein Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
3 months ago | globenewswire.com
Rein Therapeutics Announces Publication of Landmark LTI-03 Clinical Data in Nature Communications
3 months ago | globenewswire.com
Rein Therapeutics Announces Phase 2 RENEW Trial Now Enrolling Across All Five Countries
4 months ago | globenewswire.com
Rein Therapeutics Inc. (RNTX) Shareholder/Analyst Call Prepared Remarks Transcript
4 months ago | seekingalpha.com
All You Need to Know About Rein Therapeutics Inc. (RNTX) Rating Upgrade to Buy
5 months ago | zacks.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

RNTX
Rein Therapeutics
$ 0.5521
-1.41%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago